- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.07. | BONE BIOLOGICS CORPORATION: Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities | 217 | GlobeNewswire (Europe) | BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 16.07. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 09.07. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Bone Biologics enters into definitive agreement for $3.0M private placement | 1 | Seeking Alpha | ||
| 08.07. | BONE BIOLOGICS CORPORATION: Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 151 | GlobeNewswire (Europe) | BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics," or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 19.05. | Bone Biologics extends rhNELL-1 protein shelf life to 29 months | 1 | Investing.com | ||
| 19.05. | Bone Biologics verlängert Haltbarkeit von Protein rhNELL-1 auf 29 Monate | 1 | Investing.com Deutsch | ||
| 14.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.03. | Bone Biologics kündigt 'At-the-Market'-Angebot über 1,06 Millionen US-Dollar an der NASDAQ an | 1 | Investing.com Deutsch | ||
| 13.03. | Bone Biologics Corp - 8-K, Current Report | 3 | SEC Filings | ||
| 02.03. | Bone Biologics Corp - 10-K, Annual Report | 3 | SEC Filings | ||
| 08.01. | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | 448 | GlobeNewswire (Europe) | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 23.12.25 | BONE BIOLOGICS CORPORATION: Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months | 370 | GlobeNewswire (Europe) | BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,020 | -2,88 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| BUTTERFLY NETWORK | 8,410 | +0,12 % | Butterfly Network, Inc. - 8-K, Current Report | ||
| BEYOND AIR | 5,250 | +0,96 % | Beyond Air erfüllt nach Reverse Split wieder Nasdaq-Anforderungen | ||
| ACCENDRA HEALTH | 1,110 | -8,26 % | Baird downgrades Accendra Health stock rating on weak results | ||
| AXOGEN | 40,970 | -1,92 % | Axogen, Inc. Reports Second Quarter 2026 Financial Results | ALACHUA, Fla. and TAMPA, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| AETHLON MEDICAL | 3,105 | +0,81 % | XFRA NEW INSTRUMENTS AVAILABLE ON 04.08.2026 | The following instruments on XETRA do have their first trading 04.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 04.08.2026
Aktien
1 AU0000178071 Hamelin Gold Ltd.
2... ► Artikel lesen | |
| AVANOS MEDICAL | 21,600 | 0,00 % | AVANOS MEDICAL, INC. - 15-12G, Securities registration termination | ||
| APYX MEDICAL | 2,940 | -14,53 % | Apyx Medical Corporation Reports Second Quarter 2026 Financial Results | Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece... ► Artikel lesen | |
| ANGIODYNAMICS | 13,900 | +1,46 % | H.C. Wainwright raises AngioDynamics stock price target on growth | ||
| ANTERIS TECHNOLOGIES GLOBAL | 9,110 | +1,67 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Statement of CDIs on issue - AVR | ||
| ADAPTHEALTH | 5,610 | +7,47 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ENVUE MEDICAL | 0,410 | -0,97 % | ENvue Medical, Inc.: ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities | TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced it has completed the transition... ► Artikel lesen | |
| GLUCOTRACK | 0,400 | -0,72 % | Glucotrack Secures $5.5 Million Financing Through Equity And Convertible Debt | ||
| BLUEJAY DIAGNOSTICS | 0,960 | -2,76 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 9,320 | +0,32 % | Morning Market Movers: Gran Tierra Energy, Autonomix Medical, Julong Holding, Shopify See Big Swings | OTTAWA (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
Das Unternehmen BONE BIOLOGICS CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,99 % bei einem Aktienkurs von 0,908 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONE BIOLOGICS CORP finden Sie auf Wallstreet Online.